In 2016, De Vos et al. investigated NGRN/BACE1 ratio as a potential AD biomarker and found that it correlated with yearly decline in mini-mental state examination (MMSE) scores in patients with MCI and dementia due to AD (β = −0.018 and −0.051, respectively) (82). This evidence concerns the gene NGRN and Alzheimer disease.